Show simple item record

dc.contributor.authorLinton, Kim M
dc.contributor.authorDreyling, M.
dc.date.accessioned2020-10-06T13:33:40Z
dc.date.available2020-10-06T13:33:40Z
dc.date.issued2020en
dc.identifier.citationLinton K, Dreyling M. EHA Endorsement of ESMO Clinical Practice Guidelines for Newly Diagnosed and Relapsed Mantle Cell Lymphoma. Hemasphere. 2020;4(5):e464.en
dc.identifier.pmid32885149en
dc.identifier.doi10.1097/hs9.0000000000000464en
dc.identifier.urihttp://hdl.handle.net/10541/623294
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1097/hs9.0000000000000464en
dc.titleEHA endorsement of ESMO clinical practice guidelines for newly diagnosed and relapsed mantle cell lymphomaen
dc.typeOtheren
dc.contributor.departmentDivision of Cancer Sciences, School of Medicine Sciences, University of Manchester, Manchester Cancer Research Centre, Manchester, UK.en
dc.identifier.journalHemasphereen
dc.description.noteen]
refterms.dateFOA2020-10-07T08:54:11Z


Files in this item

Thumbnail
Name:
32885149.pdf
Size:
144.4Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record